Chinese Government Support Hinders M&A Potential
SHANGHAI – Few people are as well placed to understand the financing situation of China’s biomedicine sector than Mike Braun, managing partner for Deloitte’s Life Science & Health Financial Advisory Services in China.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter